Kevin P. Egan

761 total citations
20 papers, 591 citations indexed

About

Kevin P. Egan is a scholar working on Epidemiology, Genetics and Rheumatology. According to data from OpenAlex, Kevin P. Egan has authored 20 papers receiving a total of 591 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 6 papers in Genetics and 4 papers in Rheumatology. Recurrent topics in Kevin P. Egan's work include Herpesvirus Infections and Treatments (9 papers), Heterotopic Ossification and Related Conditions (4 papers) and Cytomegalovirus and herpesvirus research (4 papers). Kevin P. Egan is often cited by papers focused on Herpesvirus Infections and Treatments (9 papers), Heterotopic Ossification and Related Conditions (4 papers) and Cytomegalovirus and herpesvirus research (4 papers). Kevin P. Egan collaborates with scholars based in United States, Australia and Japan. Kevin P. Egan's co-authors include Robert J. Pignolo, Tracy A. Brennan, Stephen R. Jennings, Brian Wigdahl, Jung‐Hoon Kim, Harvey M. Friedman, Sita Awasthi, Lauren M. Hook, Emile R. Mohler and Eileen M. Shore and has published in prestigious journals such as Arteriosclerosis Thrombosis and Vascular Biology, PLoS Pathogens and Virology.

In The Last Decade

Kevin P. Egan

20 papers receiving 578 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kevin P. Egan United States 12 190 154 127 88 86 20 591
Fiona Salway United Kingdom 16 269 1.4× 214 1.4× 225 1.8× 202 2.3× 83 1.0× 20 718
J. Fraga Spain 15 217 1.1× 59 0.4× 132 1.0× 73 0.8× 78 0.9× 62 558
Bishan Dass Radotra India 15 147 0.8× 167 1.1× 134 1.1× 42 0.5× 27 0.3× 86 674
K. Aroni Greece 12 111 0.6× 125 0.8× 74 0.6× 65 0.7× 37 0.4× 45 560
Montserrat Gilaberte Spain 16 203 1.1× 122 0.8× 82 0.6× 33 0.4× 69 0.8× 31 676
Bhargavi Duvvuri United States 15 226 1.2× 366 2.4× 126 1.0× 268 3.0× 51 0.6× 26 766
Melissa Piliang United States 18 207 1.1× 128 0.8× 97 0.8× 115 1.3× 53 0.6× 80 1.1k
Bita Ansaripour Iran 16 106 0.6× 97 0.6× 115 0.9× 332 3.8× 57 0.7× 39 717
Asunción Vicente Spain 14 129 0.7× 223 1.4× 108 0.9× 39 0.4× 175 2.0× 54 668
I Mokhtar Tunisia 16 128 0.7× 81 0.5× 191 1.5× 59 0.7× 45 0.5× 76 672

Countries citing papers authored by Kevin P. Egan

Since Specialization
Citations

This map shows the geographic impact of Kevin P. Egan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin P. Egan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin P. Egan more than expected).

Fields of papers citing papers by Kevin P. Egan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin P. Egan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin P. Egan. The network helps show where Kevin P. Egan may publish in the future.

Co-authorship network of co-authors of Kevin P. Egan

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin P. Egan. A scholar is included among the top collaborators of Kevin P. Egan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin P. Egan. Kevin P. Egan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hook, Lauren M., John M. Lubinski, Kevin P. Egan, et al.. (2025). Seroconversion Is Misleading as a Test for HSV-2 Infection in Prophylactic Genital Herpes Vaccine Trials: Results of Vaccine Studies in Guinea Pigs. Viruses. 17(6). 773–773. 1 indexed citations
4.
Hook, Lauren M., Sita Awasthi, Tina M. Cairns, et al.. (2022). Antibodies to Crucial Epitopes on HSV-2 Glycoprotein D as a Guide to Dosing an mRNA Genital Herpes Vaccine. Viruses. 14(3). 540–540. 11 indexed citations
5.
Egan, Kevin P., et al.. (2020). Vaccines to prevent genital herpes. Translational research. 220. 138–152. 18 indexed citations
6.
Egan, Kevin P., Lauren M. Hook, Norbert Pardi, et al.. (2020). An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infection. PLoS Pathogens. 16(7). e1008795–e1008795. 50 indexed citations
7.
Egan, Kevin P., et al.. (2020). Herpes simplex virus type 2 trivalent protein vaccine containing glycoproteins C, D and E protects guinea pigs against HSV-1 genital infection. Human Vaccines & Immunotherapeutics. 16(9). 2109–2113. 13 indexed citations
8.
Fyfe, Billie, Kevin P. Egan, Meiqi Xu, et al.. (2018). A case report of mesenteric heterotopic ossification: Histopathologic and genetic findings. Bone. 109. 56–60. 10 indexed citations
9.
Egan, Kevin P., Gustavo Duque, Mary Ann Keenan, & Robert J. Pignolo. (2018). Circulating osteogentic precursor cells in non-hereditary heterotopic ossification. Bone. 109. 61–64. 17 indexed citations
10.
Egan, Kevin P., Alexander G. Allen, Brian Wigdahl, & Stephen R. Jennings. (2017). Modeling the pathology, immune responses, and kinetics of HSV-1 replication in the lip scarification model. Virology. 514. 124–133. 8 indexed citations
11.
Egan, Kevin P.. (2015). Academic Advising in Individualized Major Programs: Promoting the Three I’s of General Education. The Journal of General Education. 64(2). 75–89. 6 indexed citations
12.
Egan, Kevin P.. (2015). Academic Advising in Individualized Major Programs. The Journal of General Education. 64(2). 75–89. 2 indexed citations
13.
Brennan, Tracy A., Kevin P. Egan, Qijun Chen, et al.. (2014). Mouse models of telomere dysfunction phenocopy skeletal changes found in human age-related osteoporosis. Disease Models & Mechanisms. 7(5). 583–92. 32 indexed citations
14.
Egan, Kevin P., et al.. (2013). Immunological control of herpes simplex virus infections. Journal of NeuroVirology. 19(4). 328–345. 96 indexed citations
15.
Wang, Haitao, Tracy A. Brennan, Elizabeth S. Russell, et al.. (2013). R-spondin 1 promotes vibration-induced bone formation in mouse models of osteoporosis. Journal of Molecular Medicine. 91(12). 1421–1429. 27 indexed citations
16.
Egan, Kevin P., Tracy A. Brennan, & Robert J. Pignolo. (2012). Bone histomorphometry using free and commonly available software. Histopathology. 61(6). 1168–1173. 108 indexed citations
17.
Brennan, Tracy A., Jung Hoon Kim, Kevin P. Egan, et al.. (2012). Brief Report: Long-Term Functional Engraftment of Mesenchymal Progenitor Cells in a Mouse Model of Accelerated Aging. Stem Cells. 31(3). 607–611. 22 indexed citations
18.
Egan, Kevin P., Jung‐Hoon Kim, Emile R. Mohler, & Robert J. Pignolo. (2011). Role for Circulating Osteogenic Precursor Cells in Aortic Valvular Disease. Arteriosclerosis Thrombosis and Vascular Biology. 31(12). 2965–2971. 50 indexed citations
19.
Pignolo, Robert J. & Kevin P. Egan. (2010). Circulating osteogenic cells in end-stage aortic valvular disease. Bone. 47. S233–S233. 1 indexed citations
20.
Billings, Paul C., Kevin P. Egan, Jung‐Hoon Kim, et al.. (2009). Circulating Osteogenic Precursor Cells in Heterotopic Bone Formation. Stem Cells. 27(9). 2209–2219. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026